Neuren Pharmaceuticals

Professor Margaret Brimble, MNZM, FRSNZ, FRACI, FNZIC, PhD (Medicinal Chemistry)

Professor Margaret Brimble is the Chair of Organic and Medicinal Chemistry at the University of Auckland. She has extensive experience in organic synthesis, particularly of complex, biologically active molecules. She won the 2004 Novartis Chemistry Award for outstanding contributions in natural products synthesis and the development of synthetic methodology. Professor Brimble is on the International Union of Pure and Applied Chemistry (IUPAC) Committee on organic synthesis, is President-elect of the International Society of Heterocyclic Chemistry (ISHC) and is member of the Academy Council of the Royal Society of New Zealand. She has published widely and received a number of awards for her scientific achievements.

Dr John E. Dillberger, Pharmacology, Toxicology (Consultant) DVM, PhD, Diplomate ACVP and ABT, Fellow IATP

Dr Dillberger is president of J. Dillberger, LLC, a preclinical development consulting firm specialising in the application of pharmacology, toxicology, and pathology expertise to the safety evaluation of drugs, medical devices, biologics, and combination products. His clients include biopharmaceutical companies in the US, Korea, Japan, Italy, and New Zealand, as well as non-profit foundations and investment firms with pharmaceutical company portfolios.

Over his 17 years in the pharmaceutical industry, Dr Dillberger has held positions of increasing responsibility at Marion Merrell Dow, GlaxoWellcome, and Triangle Pharmaceuticals. He has served as Head of US Pathology, Director of Safety Evaluation for US-Based Development Projects, and Worldwide Specialist in Oncology Drug Projects for GlaxoWellcome and as Director of Toxicology at Triangle Pharmaceuticals. Dr Dillberger has prepared safety evaluation packages for numerous clinical trial and marketing applications in the US and Europe, including the recent NDA for Coviracil® and CTD for ThelinÔ.

Consultants